Kinetic analysis of hepatobiliary transport of drugs: Importance of carrier-mediated transport

被引:4
|
作者
Yamazaki, M
Nishigaki, R
Suzuki, H
Sugiyama, Y
机构
[1] UNIV TOKYO, FAC PHARMACEUT SCI, BUNKYO KU, TOKYO 113, JAPAN
[2] TOHO UNIV, SCH PHARMACEUT SCI, DEPT PHARMACOKINET & BIOPHARMACEUT, FUNABASHI, CHIBA 274, JAPAN
关键词
organic anion; bile acid; primary active transport; multispecific anion transporter; Eisai hyperbilirubinemic rat;
D O I
10.1248/yakushi1947.115.12_953
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The liver is the major organ involved in the metabolism and elimination of xenobiotics. Evaluating accurately hepatic clearance is very important for predicting the pharmacological effect and/or side-effects of drugs, as well as changes in drug disposition during disease. Recently, for many endogenous and exogenous compounds (including drugs), it has been reported that carrier-mediated transport contributes to hepatic uptake and/or biliary excretion. In particular, primary active transport mechanisms have been shown to be responsible for the biliary excretion of anticancer drugs, endogenous bile acids and organic anions including glutathione and glucuronic acid conjugates. We have found that a rate-limiting step for several drugs in terms of the hepatic clearance was the membrane transport process. For these drugs, such a saturable transport process can be one of the major determinants which influence not only hepatic clearance itself but also disposition (in other words, plasma elimination) in the whole body. We reviewed the carrier-mediated transport mechanisms involved in the hepatic uptake and biliary excretion processes, the multiplicity of transport systems, and further, the physiological meaning of these complex transport systems in the body.
引用
收藏
页码:953 / 977
页数:25
相关论文
共 50 条
  • [41] CARRIER-MEDIATED TRANSPORT OF BILE-ACIDS BY LIVER
    REICHEN, J
    PAUMGARTNER, G
    EXPERIENTIA, 1975, 31 (06): : 714 - 714
  • [42] CARRIER-MEDIATED TRANSPORT OF THIAMINE IN BAKERS-YEAST
    IWASHIMA, A
    NISHINO, H
    NOSE, Y
    BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 330 (02) : 222 - 234
  • [43] Coexistence of passive and carrier-mediated processes in drug transport
    Sugano, Kiyohiko
    Kansy, Manfred
    Artursson, Per
    Avdeef, Alex
    Bendels, Stefanie
    Di, Li
    Ecker, Gerhard F.
    Faller, Bernard
    Fischer, Holger
    Gerebtzoff, Gregori
    Lennernaes, Hans
    Senner, Frank
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (08) : 597 - 614
  • [44] CARRIER-MEDIATED TRANSPORT OF CHOLINE INTO SYNAPTIC NERVE ENDINGS
    DIAMOND, I
    KENNEDY, EP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1969, 244 (12) : 3258 - &
  • [45] Carrier-mediated transport to enhance drug delivery to brain
    Smith, QR
    DRUG TRANSPORT(ERS) AND THE DISEASED BRAIN, 2005, 1277 : 63 - 74
  • [46] ELECTROCHEMICAL COUPLING IN CARRIER-MEDIATED MEMBRANE-TRANSPORT
    GALLAGHER, PM
    ATHAYDE, AL
    IVORY, CF
    JOURNAL OF MEMBRANE SCIENCE, 1986, 29 (01) : 49 - 67
  • [47] CARRIER-MEDIATED TRANSPORT OF OUABAIN IN ISOLATED RAT HEPATOCYTES
    EATON, DL
    KLAASSEN, CD
    GASTROENTEROLOGY, 1977, 73 (05) : 1218 - 1218
  • [48] Coexistence of passive and carrier-mediated processes in drug transport
    Kiyohiko Sugano
    Manfred Kansy
    Per Artursson
    Alex Avdeef
    Stefanie Bendels
    Li Di
    Gerhard F. Ecker
    Bernard Faller
    Holger Fischer
    Grégori Gerebtzoff
    Hans Lennernaes
    Frank Senner
    Nature Reviews Drug Discovery, 2010, 9 : 597 - 614
  • [49] Search for carrier-mediated transport systems in the rat colon
    Tomei, S
    Hayashi, Y
    Inoue, K
    Torimoto, M
    Ota, Y
    Morita, K
    Yuasa, H
    Watanabe, J
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, 26 (02) : 274 - 277